
    
      A prospective randomized open-label study comparing dose titration group (stepwise dose
      titration of febuxostat and low-dose colchicine) and standard treatment group (fixed dose
      febuxostat and low-dose colchicine) in the subjects with gout and hyperuricemia. The
      incidence rate of gout flare will be compared between two groups during the first 12 week of
      febuxostat treatment.
    
  